Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cobenfy
Pharma
BMS turns focus to new growth drivers as legacy meds decline
The majority of Bristol Myers Squibb's $48.2 billion revenue haul in 2025 came from its collection of newer growth products.
Zoey Becker
Feb 5, 2026 11:45am
Bristol Myers CEO pledges to 'cast a broad net' in dealmaking
Jan 12, 2026 4:28pm
BMS' Cobenfy TV ad is latest target of FDA untitled letter spree
Dec 19, 2025 10:44am
With site 'irregularities,' BMS delays key Cobenfy readout
Dec 3, 2025 10:14am
Cobenfy delivers OK debut year as BMS works to ease nerves
Oct 30, 2025 11:19am
BMS cooks up schizophrenia stigma-busting push with Gail Simmons
Oct 13, 2025 11:29am
